Bioregenx, Inc.
FDIT
Revenue
734.03k
▲184.48k▲33.57%
3 Months ChangeAssets
17.89M
▼-729.12k▼-3.92%
3 Months ChangeLiabilities
3.67M
▲134.95k▲3.82%
3 Months ChangeFree Cash Flow
-293.64k
▲43.15k▲12.81%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-06-11
Form 8-K
ID: 0001683168-24-004095
2024-05-24
Form 10-Q
ID: 0001683168-24-003807
2024-05-16
Form 8-K
ID: 0001683168-24-003582
2024-04-01
Form 8-K
ID: 0001683168-24-001917
2023-11-20
Form 10-Q
ID: 0001683168-23-008360
2023-08-15
Form 10-Q
ID: 0001683168-23-005813
2023-05-22
Form 10-Q
ID: 0001683168-23-003620
2023-01-06
Form 8-K
ID: 0001800943-23-000001
2022-11-21
Form 10-Q
ID: 0001800943-22-000015
2022-08-12
Form 10-Q
ID: 0001800943-22-000013